News & Updates
Filter by Specialty:
Large UK study underpins role of COVID-19 vax in mental illness
In a cohort study of over 18 million individuals with up to 2 years of follow-up, the incidences of most mental illnesses were markedly elevated following COVID-19 diagnosis compared with before or without COVID-19, particularly among the unvaccinated and before COVID-19 vaccines became available.
Large UK study underpins role of COVID-19 vax in mental illness
27 Sep 2024
Study warns of increased PD risk among people with upper GI mucosal damage history
A history of upper gastrointestinal (GI) mucosal damage, such as peptic ulcer disease and erosions, has been associated with subsequent incidence of Parkinson’s disease (PD) in a study.
Study warns of increased PD risk among people with upper GI mucosal damage history
17 Sep 2024
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
The use of tenecteplase in the extended time window of 4.5–24 hours improves functional outcomes in patients with ischaemic stroke when endovascular thrombectomy (EVT) is not immediately available, findings from the phase III TRACE-III* trial suggest.
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
11 Sep 2024
High leptin levels linked to lower risk of Alzheimer’s disease
A study has recently observed the possible protective effect of leptin against the development of Alzheimer’s disease (AD) by improving insulin sensitivity.